跳至主要内容
临床试验/NCT01279122
NCT01279122Unknown4 期

Evaluation of Visual Outcomes of Monovision Patients Bilaterally Implanted With Nanoflex Intraocular Lenses

Innovative Medical1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
Uncorrected Near Visual Acuity

研究概览

简要总结

The purpose of this study is to look at how well you see the Nanoflex Intraocular lens placed in your eye.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients at least 18 years of age.
  • Patients who have bilateral NanoFlex implantation at least 3 months previously.
  • No significant ocular pathology causing DCVA to be less than 20/25 or causing significant visual loss.
  • DCVA of 20/25 or better in both eyes.
  • Spherical equivalent in the dominant eye to be +/-.50 or less and in the non-dominant eye to be between-1.00 and -1.
  • Uncorrected VA in dominant eye 20/25 or better.

排除标准

  • History of ocular trauma or prior ocular surgery (minor ocular trauma is allowed such as small superficial corneal scar not effecting vision; some prior ocular surgery is allowable so long as it has not impacted visual acuity.
  • Amblyopia or strabismus, significant visual field loss, or posterior capsular opacifcation.
  • Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.).

结局指标

主要结局

Uncorrected Near Visual Acuity

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验